| scholarly article | Q13442814 |
| P356 | DOI | 10.3904/KJIM.1995.10.2.94 |
| P8608 | Fatcat ID | release_6kf745cf3bgebniuhziwu2pm2q |
| P932 | PMC publication ID | 4532038 |
| P698 | PubMed publication ID | 7495780 |
| P5875 | ResearchGate publication ID | 15702883 |
| P2093 | author name string | S S Kim | |
| J M Cho | |||
| D H Park | |||
| B S Kim | |||
| Y M Park | |||
| W S Ryu | |||
| H S Sun | |||
| C D Lee | |||
| K S Shim | |||
| S K Yoon | |||
| P2860 | cites work | High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR | Q22242246 |
| Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 | ||
| Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis | Q27860811 | ||
| Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis | Q29547897 | ||
| Molecular typing of hepatitis C virus genome from sera and liver tissues of patients with anti-HCV positive chronic liver disease | Q35939065 | ||
| Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial | Q41839327 | ||
| Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. | Q41937839 | ||
| Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial | Q42008293 | ||
| Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction | Q42600201 | ||
| Clinical backgrounds of the patients having different types of hepatitis C virus genomes | Q42980988 | ||
| Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus | Q42981586 | ||
| Detection of hepatitis C virus RNA by nested polymerase chain reaction in sera of patients with chronic non-A, non-B hepatitis treated with interferon | Q42982490 | ||
| The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients | Q42983268 | ||
| Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C | Q42984730 | ||
| Distribution of plural HCV types in Japan | Q42985948 | ||
| Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region | Q42986907 | ||
| Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection | Q43037452 | ||
| Genotypic subtyping of hepatitis C virus | Q43048277 | ||
| Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy | Q43048405 | ||
| A proposed system for the nomenclature of hepatitis C viral genotypes | Q43049109 | ||
| Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection | Q43049113 | ||
| Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. | Q43049490 | ||
| There are two major types of hepatitis C virus in Japan | Q43993360 | ||
| Hepatitis C virus antibodies among risk groups in Spain | Q45844599 | ||
| HCV genotypes in chronic hepatitis C and response to interferon | Q67517374 | ||
| Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report | Q70313812 | ||
| An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C | Q70590241 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 94-102 | |
| P577 | publication date | 1995-07-01 | |
| P1433 | published in | The Korean journal of internal medicine | Q26842387 |
| P1476 | title | Predictive factors for beneficial response to interferon-alfa therapy in chronic hepatitis C. | |
| P478 | volume | 10 |
| Q43036691 | Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection. |
| Q45755300 | Predictive factors in eradicating hepatitis C virus using a relatively small dose of interferon |
| Q35937739 | The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV |
Search more.